Research Projects & Grants

College/University

  • A Randomized, Comparative Effectiveness Study of Staged Complete Revascularization with Percutaneous Coronary Intervention to Treat Coronary Artery Disease vs Medical Management Alone in Patients with Symptomatic Aortic Valve Stenosis undergoing Elective Transfemoral Transcatheter Aortic Valve Replacement: The COMPLETE TAVR Study, Role: Investigator, University of British Columbia, (04/2024 - 04/2025) Status: Approved

For Profit Organization

  • GORE® CARDIOFORM Septal Occluder and Antiplatelet medical management for reduction of recurrent stroke in patients with Patent Foremen Ovale (PFO): The REDUCE post approval study, Role: Investigator, W.L. Gore & Associates, Inc., (06/2024 - 06/2025) Status: Approved
  • SSO2 THERAPY: AMIHOT III STUDY: A MULTI-CENTER RANDOMIZED POST-APPROVAL EVALUATION OF THE DELIVERY OF INTRACORONARY HYPEROXEMIC SUPERSATURATED OXYGEN THERAPY FOR 60 MINUTES IN ANTERIOR ACUTE MYOCARDIAL INFARCTION PATIENTS WITH SUCCESSFUL REPERFUSION (VIA PCI) = SIX HOURS AFTER SYMPTOM ONSET COMPARED TO STANDARD THERAPY, Role: Investigator, TherOx, Inc., (05/2024 - 05/2025) Status: Approved
  • Impella®-Supported PCI in High-Risk Patients with Complex Coronary Artery Disease and Reduced Left Ventricular Function: The PROTECT IV Trial, Role: Investigator, ABIOMED, Inc., (01/2024 - 01/2025) Status: Approved

Internal

  • HUD: PK Papyrus Covered Coronary Stent System, Role: Investigator, LLU Dept. of Medicine, (05/2024 - 05/2025) Status: Approved